Polar Asset Management Partners Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 400 shares of REGN stock, worth $289,948. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400
Previous 1,300
69.23%
Holding current value
$289,948
Previous $1.37 Million
69.25%
% of portfolio
0.01%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,535Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.76 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.12 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.43 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.55 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.12 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $77.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...